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Objectives:  Impairment  of  blood  rheology  has  been  reported  to  be  associated  with  cardiovascular  dis-
eases. Recently,  visible  micro  channel  methods  [micro  channel  array  ﬂow  analyzer  (MC-FAN)]  have  been
developed  to clinically  evaluate  blood  rheology.  The  aim  of  this  cross-sectional  study  is to clarify  the
factors  important  for  impairment  of blood  rheology  in obese  subjects  using  MC-FAN.
Methods:  One hundred  and  ﬁfty-nine  obese  subjects  and  100  non-obese  subjects  with  no  history  of cardio-
vascular  diseases  were  enrolled.  Blood  passage  time  (BPT)  was  measured  using  MC-FAN  and  relationships
between  BPT  and  various  clinical  parameters  were  examined.
Results:  BPT  was  signiﬁcantly  higher  in  obese  subjects  than  in  non-obese  subjects  (obesity  vs.  non-obesity:
62.8  ± 17.9  s vs.  54.1  ± 14.6  s,  p < 0.001);  however,  there  were  no  signiﬁcant  relationships  between  BPT
and body  mass  index  or waist  circumference  in  obese  subjects.  BPT  was  signiﬁcantly  related  to  systolic
blood  pressure  levels  (r =  0.21;  p < 0.001),  high-sensitivity  C-reactive  protein  concentrations  (r  = 0.37;
p  < 0.001),  a marker  of inﬂammation,  and  derivatives  of reactive  oxygen  metabolites  test (r  =  0.38;
p  < 0.001),  a marker  of  oxidative  stress,  smoking,  and exercise  habits  in  obese  subjects.  Furthermore,  mul-
tivariate analysis  revealed  that  derivatives  of  reactive  oxygen  metabolites  test  (t = 5.2;  p  < 0.001),  high
sensitivity  C-reactive  protein  concentration  (t = 3.6;  p < 0.01),  smoking  (t =  3.2; p <  0.001),  and  exercise
habits  (t =  −2.4;  p  < 0.05)  were  independent  variables  for  BPT.
Conclusion:  Data  indicate  that  inﬂammation,  oxidative  stress,  and  lifestyle  choices  are  more  important
factors  for  impairment  of  blood  rheology,  which  is  evaluated  by MC-FAN,  than  the  degree  of  adiposity  in
obese subjects.
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Obesity is associated with lifestyle and genetic factors, and is
nown to be one of the most important cardiovascular risk fac-
ors. Recent epidemiological studies have pointed out that except
n young females, obesity has been increasing among the Japanese
opulation because of high-fat diets and poor exercise habits.
Impairment of blood rheology has been reported to have
ncreased in patients with lifestyle-related diseases, such as hyper-
ension or dyslipidemia [1,2], and also in those with cardiovascular
iseases [3,4]. A commercial device, the micro channel array ﬂow
nalyzer (MC-FAN), has been used to clinically evaluate blood
heology using microscopic images [MC-FAN HR300 rheometer
MC  Laboratory, Inc., Tokyo, Japan)] [5]. MC-FAN is superior to
ther methods in accuracy of channel dimensions and high repro-
ucibility, and a number of studies have reported the clinical
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advantages of MC-FAN in evaluating blood rheology and microcir-
culation [6–9]. On the other hand, little is known about the factors
important for impairment of blood rheology, which is evaluated
by MC-FAN in obese subjects. Here, we examined the relation-
ships between blood rheology, which is evaluated by MC-FAN,
and various clinical parameters to clarify the clinical signiﬁ-
cance of blood rheology as a cardiovascular risk factor in obese
subjects.
Methods
Subjects
Blood rheology and various clinical parameters were analyzed in
159 consecutive obese subjects and 100 non-obese subjects with no
history of cardiovascular events who  visited the Hitsumoto Medi-
cal Clinic in Shimonoseki city between January 2008 and December
2009 and consented to this cross-sectional study. Obesity was  esti-
mated by determining the body mass index (BMI), which was
calculated as weight (in kg) divided by height squared (in m2).
Subjects with a BMI  ≥ 25 were deﬁned as obese. Subjects who
vier Ltd. All rights reserved.
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Fig. 1. Evaluation of blood rheology using micro channel array ﬂow analyzer (MC-FAN). Left side shows system of MC-FAN. The micro channel passage time of 100 l of
physiologic saline was  measured as a control, and then that of venous blood obtained from the subjects with 5% heparinization was determined. The blood passage time
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sBPT)  of the subjects was  expressed after correction for the passage time of physiol
lood  sample passed.
nderwent antiplatelet or anticoagulant therapy were excluded.
he study protocol was approved by the local ethics committee.
valuation of blood rheology by MC-FAN
Blood samples were collected from the antecubital vein in the
orning after 12 h of fasting, and evaluation of blood rheology
as performed within 60 min  after blood sampling. Evaluation of
lood rheology was performed by measuring the blood passage
ime (BPT) using the MC-FAN as reported previously (Fig. 1) [7].
rieﬂy, the microchannel passage time of 100 l of physiological
aline was ﬁrst measured as a control, and then that of the blood
amples obtained from the subjects with 5% heparinization was
etermined. The BPT of the subjects was expressed after correction
or the passage time of physiological saline. In this system, BPT can
e measured within 120 s and subjects with a BPT more than 120 s
ere excluded.
valuation of cardiovascular risk factors
Right brachial blood pressure was measured twice using a mer-
urial sphygmomanometer in a sitting position. The average of
wo readings was used to determine systolic and diastolic blood
ressures. Considering the blood parameters, blood cell counts,
erum lipid concentrations, plasma glucose concentrations, plasma
nsulin concentrations, hemoglobin A1c, serum high-sensitivity
-reactive protein (hs-CRP) concentrations, and derivatives of
eactive oxygen metabolites (d-ROMs) test were measured. Total
holesterol and triglyceride concentrations were measured by
tandard enzymatic methods. High-density lipoprotein choles-
erol concentration was measured by selective inhibition. The
oncentration of low-density lipoprotein cholesterol was  calcu-
ated by Friedewald’s formula [10]. Glucose concentration was
easured by the glucose oxidase method, and insulin concen-
rations were measured by enzyme immunoassay. Hemoglobin
1c concentration was measured by standard laboratory pro-
edures and data were expressed using the value of National
lycohemoglobin Standardization Program. To measure insulin
esistance, the homeostatic model assessment of insulin resis-
ance (HOMA-IR) was used as follows [11]: HOMA-IR = fasting
lucose concentrations [mg/dl] × fasting insulin concentrations
g/ml]/405. Concentrations of hs-CRP were measured using high-
ensitivity, latex-enhanced immunonephelometrics. The d-ROMsaline. Right side shows result of a case. BPT was evaluated by the time with 100 l
test, which reﬂects hydroperoxides, was  measured as an oxidative
stress marker in vivo using a commercial device (Diacron, Grosseto,
Italy) [12]. Lifestyle was estimated based on smoking and exercise
habits. Smoking was  considered positive for those who habitually
smoked cigarettes at the start of the study. Exercise habits were
considered positive for those who  performed aerobic exercise for
more than 30 min  three times a week.
Statistical analysis
A commercially available statistical software program
(StatView-J 5.0; Hulinks, Inc., Tokyo, Japan) was used for all
statistical analyses. Continuous variables were expressed as the
mean ± standard deviation. Between-group comparisons were
performed using the Student’s t-test. The correlation coefﬁcient
was estimated by Spearman’s rank correlation analysis. Multivari-
ate analysis was  performed using multiple regression analysis. A
p-value of less than 0.05 was considered statistically signiﬁcant.
Results
Clinical characteristics
Baseline clinical characteristics are shown in Table 1. The mean
BMI  in obese subjects was  27.5 kg/m2 and in non-obese subjects
was 21.0 kg/m2. Blood pressure levels, serum low-density lipopro-
tein cholesterol, and triglyceride concentration, HOMA-IR, a marker
of insulin resistance, hs-CRP concentrations, a marker of inﬂam-
mation, and d-ROMs test, a marker of oxidative stress in vivo were
signiﬁcantly higher in obese subjects than in non-obese subjects.
BPT was also signiﬁcantly higher in obese subjects than in non-
obese subjects; but BPT in obese subjects was  widely distributed
from 35.1 to 116.2 s.
Relationships between blood rheology and various clinical
parameters
Relationships between BPT and various clinical parameters in
obese subjects are shown in Table 2 and Fig. 2. There was a no
signiﬁcant correlation between BPT and BMI, waist circumfer-
ence or HOMA-IR, a marker of insulin resistance. Furthermore, the
relationship between BPT and BMI  or waist circumference was eval-
uated based on the gender differences; however, BPT showed no
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Table  1
Baseline clinical characteristics.
Obesity (−)
(n = 100)
Obesity (+)
(n = 159)
p-Value
Age (years) 63 ± 11 64 ± 12 0.33
Male/female 42/58 67/92 0.98
Body mass index (kg/m2) 21.0 ± 2.0 27.5 ± 3.0 <0.001
West circumference (cm) 80 ± 6 94 ± 7 <0.001
Smoking (%) 16 (16) 35 (22) 0.23
Exercise habits (%) 39 (39) 48 (30) 0.15
Systolic blood pressure
(mmHg)
124 ± 21 141 ± 13 <0.001
Diastolic blood pressure
(mmHg)
72 ± 8 83 ± 9 <0.001
Total cholesterol (mg/dl) 187 ± 32 201 ± 44 <0.001
LDL  cholesterol (mg/dl) 108 ± 30 140 ± 43 <0.001
Triglyceride (mg/dl) 71 ± 18 156 ± 55 <0.001
HDL cholesterol (mg/dl) 55 ± 12 49 ± 16 <0.01
Fasting blood glucose
(mg/dl)
96 ± 7 106 ± 9 <0.01
Immunoreactive insulin
(g/ml)
5.0 ± 2.0 10.6 ± 4.3 <0.01
Hemoglobin A1c (%) 5.3 ± 0.9 5.6 ± 1.0 <0.05
HOMA-IR 1.2 ± 0.5 2.8 ± 1.2 <0.001
White blood cell count
(/l)
5530 ± 1120 7020 ± 1400 <0.001
Red  blood cell count
(104/l)
442 ± 82 518 ± 74 <0.001
Platelet count (104/l) 21.6 ± 6.0 22.1 ± 6.2 0.72
Log-hs-CRP (mg/L) −1.3 ± 0.4 −1.1 ± 0.5 <0.01
d-ROMs test (U.Carr) 314 ± 64 342 ± 71 <0.01
BPT  (s) 54.1 ± 14.6 62.8 ± 17.9 <0.001
ACE-i/ARB (%) 10 (10) 45 (28) <0.001
Calcium-channel blockers
(%)
8  (8) 41 (26) <0.001
-Blocker (%) 2 (2) 6 (4) 0.42
Statin (%) 10 (10) 32 (20) <0.05
Blood-sugar lowering
drugs (%)
6 (6) 16 (10) <0.05
LDL, low-density lipoprotein; HDL, high-density lipoprotein; HOMA-IR, homeo-
stasis assessment insulin resistance; hs-CRP, high-sensitivity C-reactive protein;
d-ROMs, derivatives of reactive oxygen metabolites; BPT, blood passage time; ACE-I,
angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker. Con-
tinuous values are mean ± SD.
Table 2
Correlation between blood passage time and clinical parameters of statistically non-
signiﬁcant factors in obese subjects.
r p-Value
Age −0.11 0.17
Gender (male = 1, female = 0) 0.14 0.08
Body mass index
All subjects 0.07 0.36
Male −0.05 0.70
Female 0.18 0.08
Waist circumference
All subjects 0.07 0.36
Male −0.04 0.76
Female 0.17 0.11
Total cholesterol 0.14 0.07
LDL cholesterol 0.14 0.07
Triglyceride 0.10 0.20
HDL cholesterol −0.05 0.53
Fasting blood glucose 0.02 0.80
Immunoreactive insulin 0.04 0.60
Hemoglobin A1c 0.03 0.67
HOMA-IR 0.05 0.51
White blood cell count 0.05 0.52
Platelet count 0.10 0.19
ACE-I/ARB (Yes = 1, No = 0) −0.13 0.10
Calcium-channel blockers (Yes = 1, No = 0) 0.11 0.18
-Blocker (Yes = 1, No = 0) 0.10 0.20
Statin (Yes = 1, No = 0) −0.11 0.18
Blood-sugar lowering drugs (Yes = 1, No = 0) −0.07 0.35
LDL, low-density lipoprotein; HDL, high-density lipoprotein; HOMA-IR, homeosta-
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Fig. 2. Correlation between blood passage time and clinical parameters of statistically sig
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signiﬁcant correlation with BMI  or waist circumference in males or
females. Relationships between BPT and medications such as anti-
hypertensive drugs, statins, and blood sugar-lowering drugs were
also evaluated; however, BPT was  not affected by medications. In
contrast, BPT showed signiﬁcantly positive correlations with sys-
tolic blood pressure, diastolic blood pressure, red blood cell count,
log-hs-CRP concentration, and d-ROMs test.
The relationships between BPT and lifestyle factors in obese
subjects are shown in Fig. 3. BPT was signiﬁcantly higher in
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obese subjects, and they indicated a signiﬁcant positive correlation
between BPT and BMI  or waist circumference [13]. The authors also
speculated that BPT was regulated by excess adipose tissues, which
is in contrast to the results obtained in this study. The reasons for
Table 3A
Multiple regression analysis for blood passage time in all subjects.
Standard regression
coefﬁcient
t-Value p-Value
Explanatory factor
d-ROMs test 0.32 6.4 <0.001
Log-hs-CRP 0.27 5.1 <0.001
Smoking 0.20 3.9 <0.001
Systolic blood pressure 0.17 2.3 <0.05
Exercise habits −0.12 −2.2 <0.05
Red  blood cell count 0.07 1.4 0.15
Diastolic blood pressure 0.06 0.9 0.40
Obesity 0.03 0.4 0.67
R2 = 0.40, F value = 20.5, p < 0.001 (n = 259).
Table 3B
Multiple regression analysis for blood passage time in obese subjects.
Standard regression
coefﬁcient
t-Value p-Value
Explanatory factor
d-ROMs test 0.35 5.2 <0.001
Log-hs-CRP 0.25 3.6 <0.001
Smoking 0.22 3.2 <0.01
Exercise habits −0.16 −2.4 <0.05
Red  blood cell count 0.12 1.8 0.07Daily consumption  of  tobacco  (n)
Fig. 3. Relationships between blood passage time (BPT)
ubjects who smoked or did not exercise regularly compared
ith non-smokers or regular exercisers [smoking (+) vs. smok-
ng (−): 72.8 ± 21.4 s vs. 60.0 ± 15.8 s, p < 0.001; exercise habits
−) vs. exercise habits (+): 65.7 ± 17.9 s vs. 56.1 ± 16.2 s, p < 0.01]
Fig. 3A). Furthermore, the BPT had signiﬁcant positive correlations
ith the daily consumption of tobacco and duration of smoking
Fig. 3B).
Relationships between BPT and various clinical parameters
n non-obese subjects are also examined. BPT showed signiﬁ-
ant relations with d-ROMs test (r = 0.38, p < 0.001), log-hs-CRP
oncentration (r = 0.37, p < 0.001), and smoking habits [smoking
+) vs. smoking (−): 64.7 ± 18.2 s vs. 52.0 ± 13.0 s, p < 0.001].
ultivariate analysis
To further investigate the independent factors of BPT, multiple
egression analysis was performed using eight or seven explana-
ory factors (systolic blood pressure, diastolic blood pressure,
ed blood cell count, hs-CRP concentration, d-ROMs test, obe-
ity (Yes = 1, No = 0), smoking (Yes = 1, No = 0), and exercise habits
Yes = 1, No = 0)) to explain BPT as a subordinate factor. Five factors
d-ROMs test, hs-CRP concentration, smoking, systolic blood pres-
ure, and exercise habits) were selected as independent variables
or BPT in all subjects (Table 3A), and four factors (d-ROMs test, hs-
RP concentration, smoking, and exercise habits) were selected as
ndependent variables for BPT in obese subjects (Table 3B).
iscussion
BPT was signiﬁcantly higher in obese subjects than in non-obese
ubjects; however, multivariate analysis including both obese and
on-obese subjects showed that presence of obesity itself was not
elected as an independent variable for BPT. Furthermore, BPT was
ot affected by the degree of adiposity in obese subjects. In contrast,
PT showed a signiﬁcant relationship with hs-CRP concentrations,
 marker of inﬂammation, d-ROMs test, a marker of oxidative stress
n vivo, smoking, and aerobic exercise habits in obese subjects.(yrs)  Dura tion  of smo king  
moking habits or exercise (Ex) habits in obese subjects.
Multiple regression analysis identiﬁed these factors as independent
variables with BPT as a subordinate factor.
Excess adipose tissue plays a central role, directly or indirectly,
in various health problems in obese subjects. Satoh et al. examined
the relationships between BMI  or waist circumference and BPT inSystolic blood pressure 0.13 1.7 0.09
Diastolic blood pressure 0.08 1.0 0.31
d-ROMs, derivatives of reactive oxygen metabolites; hs-CRP, high-sensitivity C-
reactive protein. R2 = 0.32, F value = 18.5, p < 0.001 (n = 159).
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his discrepancy remain unclear. However, the results of this study
ndicate that impairment of blood rheology is not inﬂuenced by
he degree of adiposity, and other factors that might be responsi-
le for impairment of blood rheology in obese subjects should be
onsidered.
Insulin resistance is also known to play an active role in the
athogenesis of obesity by affecting processes such as glucose
olerance or lipid metabolism. In addition, several studies have clar-
ﬁed the close relationship of insulin resistance and atherosclerosis
14–16]. However, in this study, there was no signiﬁcant relation-
hip between HOMA-IR, a marker of insulin resistance, and BPT.
herefore, even though insulin resistance plays an important role
n atherosclerosis progression, results of this study indicate that
nsulin resistance poorly affects blood rheology in obese subjects.
Recent basic and clinical studies have illustrated that chronic
nﬂammation and oxidative stress in arterial walls contribute
o the development of atherosclerosis [17–21].  Furthermore, the
esults of this study indicate that inﬂammation and oxidative stress
ffect impairment of blood rheology in obese subjects. Several
echanisms by which inﬂammation and oxidative stress cause
mpairment of blood rheology, such as platelet aggregation and
levation of plasma viscosity, were considered [22,23]. By con-
rast, various drugs, including vasodilators and statins, have been
eported to decrease inﬂammation and oxidative stress in vivo
24–26]. In this cross-sectional study, there was no signiﬁcant rela-
ionship between BPT and medications such as anti-hypertensive
rugs or statins; however, intervention studies are warranted to
xamine the effectiveness of various drugs on BPT, inﬂammation,
nd oxidative stress. Consequently, we expect to discover new
pplications of drugs for the prevention of cardiovascular diseases
n obese subjects.
Smoking and lack of aerobic exercise are known to be closely
ssociated with adverse health outcomes. Therefore, guidelines for
ardiovascular disease prevention strongly recommend smoking
essation and daily aerobic exercise. Results of this study also indi-
ated that smoking and lack of aerobic exercise were important
actors for impairment of blood rheology in obese subjects. Shi-
ada et al. reported that BPT was positively correlated with daily
onsumption of tobacco or Brinkman’s index, and three months
f smoking cessation signiﬁcantly reduced BPT [27]. On the other
and, multiple studies have indicated the importance of aerobic
xercise for blood rheology through the improvement of plasma
iscosity [28,29]. Thus, smoking and aerobic exercise habits should
e considered more strongly than the degree of adiposity in obese
ubjects in order to improve blood rheology and prevent cardio-
ascular events in obese subjects.
imitations
This was a cross-sectional study with a relatively small popu-
ation conducted in a single unit. A prospective study involving a
arger number of patients is necessary to conﬁrm the effectiveness
f intervention therapies, such as anti-inﬂammatory, anti-oxidant,
moking cessation, and aerobic exercise for improving blood rheol-
gy, which is estimated by MC-FAN in obese subjects. Furthermore,
n extensive examination of basic and clinical studies will be
equired in the future to investigate the signiﬁcance of blood rhe-
logy as a cardiovascular risk factor in obese subjects.
onclusionsThe present study using MC-FAN indicated that inﬂammation,
xidative stress, and lifestyle habits such as smoking and daily
erobic exercise are more important factors for impairment of
lood rheology than the degree of adiposity in obese subjects.
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